Rapamycin carbonate esters

[thumbnail of US20090253733 JEM.pdf]
Preview
Text - Published Version
· Please see our End User Agreement before downloading.
| Preview

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Alan Rhodes (2009) Rapamycin carbonate esters. US/2009/0253733. doi: US/2009/0253733

Abstract/Summary

Certain embodiments include carbonate esters of rapamycin at position 42 that are synthesized by a lipase catalyzed regio-specific process. These compounds or a pharmaceutically acceptable salt thereof are useful in the treatment of organ and tissue transplant rejection, autoimmune disease, proliferative disorder, restenosis, cancer, or microbial infection.

Altmetric Badge

Item Type Patent
URI https://reading-clone.eprints-hosting.org/id/eprint/31360
Identification Number/DOI US/2009/0253733
Divisions Interdisciplinary centres and themes > Chemical Analysis Facility (CAF) > Mass Spectrometry (CAF)
Life Sciences > School of Chemistry, Food and Pharmacy > Department of Chemistry
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar